134 related articles for article (PubMed ID: 10643874)
1. Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy.
Brambilla F; Bellodi L; Perna G
Psychiatry Res; 1999 Dec; 89(1):21-7. PubMed ID: 10643874
[TBL] [Abstract][Full Text] [Related]
2. Personality dimensions in panic disorder before and after effective treatment.
Starcevic V; Uhlenhuth EH
Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
[No Abstract] [Full Text] [Related]
3. [Clinical picture and treatment of agoraphobia with panic disorder].
Litvintsev SV; Reznik AM; Kvashnina NV; Arbuzov AL; Krylov KE
Voen Med Zh; 2003 Jun; 324(6):53-9. PubMed ID: 12916423
[No Abstract] [Full Text] [Related]
4. Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.
Bond AJ; Curran HV; Bruce MS; O'Sullivan G; Shine P
J Affect Disord; 1995 Dec; 35(3):117-23. PubMed ID: 8749839
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
6. Effect of pharmacotherapy on serum cholesterol levels in patients with panic disorder.
Shioiri T; Fujii K; Someya T; Takahashi S
Acta Psychiatr Scand; 1996 Mar; 93(3):164-7. PubMed ID: 8739659
[TBL] [Abstract][Full Text] [Related]
7. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
8. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
[No Abstract] [Full Text] [Related]
9. Decreased plasma cortisol level during alprazolam treatment of panic disorder: a case report.
Fukuda M; Takazawa S; Nakagome K; Iwanami A; Hata A; Kasai K; Hiramatsu K
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):909-15. PubMed ID: 9723127
[TBL] [Abstract][Full Text] [Related]
10. Agoraphobia and panic disorder: 3.5 years after alprazolam and/or exposure treatment.
Kiliç C; Noshirvani H; Başoğlu M; Marks I
Psychother Psychosom; 1997; 66(4):175-8. PubMed ID: 9259039
[TBL] [Abstract][Full Text] [Related]
11. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
[TBL] [Abstract][Full Text] [Related]
12. Sertraline and alprazolam in the treatment of panic desorder.
Fiseković S; Loga-Zec S
Bosn J Basic Med Sci; 2005 May; 5(2):78-81. PubMed ID: 16053461
[TBL] [Abstract][Full Text] [Related]
13. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
Sheehan DV; Sheehan KH; Raj BA
Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
[TBL] [Abstract][Full Text] [Related]
14. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
15. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
Brambilla F; Perna G; Garberi A; Nobile P; Bellodi L
Psychoneuroendocrinology; 1995; 20(1):1-9. PubMed ID: 7838898
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenergic receptor sensitivity in panic disorder: II. Cortisol response to clonidine stimulation in panic disorder.
Brambilla F; Bellodi L; Arancio C; Nobile P; Perna G
Psychoneuroendocrinology; 1995; 20(1):11-9. PubMed ID: 7838899
[TBL] [Abstract][Full Text] [Related]
17. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
18. Efficacy studies of alprazolam in panic disorder.
Spiegel DA
Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.
Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ
J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152
[TBL] [Abstract][Full Text] [Related]
20. Adrenocorticotropic hormone and cortisol responses to corticotropin-releasing hormone: changes in panic disorder and effects of alprazolam treatment.
Curtis GC; Abelson JL; Gold PW
Biol Psychiatry; 1997 Jan; 41(1):76-85. PubMed ID: 8988798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
